Pershing Square Activist Presentation Deck slide image

Pershing Square Activist Presentation Deck

Standalone Allergan vs. Val-gan Allergan "Standalone" Sources of Incremental Value ► M&A ► R&D Success ► Cost Savings Transaction Sources of Value ► Cost Synergies ► Organic Growth ► Business Development } 102 Mixed track record Valeant has achieved announced cost synergies in all announced transactions Upside
View entire presentation